Skip to main content

Table 9 Association between lipodystrophy and the metabolic syndrome and its individual components in men

From: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

 

Model 1

OR (95% CI)

Model 2

OR (95% CI)

Model 3

OR (95% CI)

MS ATP III

1.017 (0.598-1.731)

0.621 (0.324-1.191)

0.931 (0.460-1.884)

High waist circumference

0.508 (0.260-0.991)

0.403 (0.187-0.865)

--

Hypertriglyceridemia

1.846 (0.940-3.624)

1.677 (0.782-3.600)

2.019 (0.899-4.531)

Low HDL cholesterol

1.261 (0.686-2.319)

1.116 (0.562-2.216)

1.304 (0.639-2.661)

High fasting glucose

1.254 (0.734-2.143)

1.004 (0.540-1.868)

1.256 (0.654-2.409)

High blood pressure

0.905 (0.532-1.540)

0.458 (0.223-0.939)

0.567 (0.270-1.191)

MS IDF

0.694 (0.402-1.196)

0.519 (0.274-0.985)

1.058 (0.473-2.365)

High waist circumference

0.585 (0.342-1.001)

0.491 (0.260-0.929)

--

Hypertriglyceridemia

1.846 (0.940-3.624)

1.677 (0.782-3.600)

2.019 (0.899-4.531)

Low HDL cholesterol

1.261 (0.686-2.319)

1.116 (0.562-2.216)

1.304 (0.639-2.661)

High fasting glucose

1.130 (0.661-1.931)

0.940 (0.506-1.743)

1.143 (0.599-2.180)

High blood pressure

0.905 (0.532-1.540)

0.458 (0.223-0.939)

0.567 (0.270-1.191)

  1. Model 1 - OR crude
  2. Model 2 - OR adjusted for gender, age and cART
  3. Model 3 - OR adjusted for gender, age, duration of cART and BMI